MX2010005690A - Variantes de proteasa para uso farmaceutico. - Google Patents

Variantes de proteasa para uso farmaceutico.

Info

Publication number
MX2010005690A
MX2010005690A MX2010005690A MX2010005690A MX2010005690A MX 2010005690 A MX2010005690 A MX 2010005690A MX 2010005690 A MX2010005690 A MX 2010005690A MX 2010005690 A MX2010005690 A MX 2010005690A MX 2010005690 A MX2010005690 A MX 2010005690A
Authority
MX
Mexico
Prior art keywords
variants
pharmaceutical use
treatment
protease variants
diabetes type
Prior art date
Application number
MX2010005690A
Other languages
English (en)
Inventor
Allan Svendsen
Peter Colin Gregory
Signe Eskildsen Larsen
Lars Beier
Thomas Lenhard
Tanja Maria Rosenkilde Kjaer
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Publication of MX2010005690A publication Critical patent/MX2010005690A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La invención se relaciona con variantes nuevas de una proteasa derivada del Nocardiopsis sp. (SEQ ID NO:1) y proteasas relacionadas de cerca, así como su uso farmacéutico. Las variantes muestran funcionamiento mejorado en el tratamiento de insuficiencia exocrina pancreática (PEI). Las variantes pueden ser combinadas con una lipasa y/o una amilasa. Otros ejemplos de indicaciones médicas son: tratamiento de trastornos digestivos, pancreatitis, fibrosis quística, diabetes tipo I, y/o diabetes tipo II.
MX2010005690A 2007-12-04 2008-12-02 Variantes de proteasa para uso farmaceutico. MX2010005690A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07122243 2007-12-04
PCT/EP2008/066646 WO2009071550A1 (en) 2007-12-04 2008-12-02 Protease variants for pharmaceutical use

Publications (1)

Publication Number Publication Date
MX2010005690A true MX2010005690A (es) 2010-06-08

Family

ID=40310217

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010005690A MX2010005690A (es) 2007-12-04 2008-12-02 Variantes de proteasa para uso farmaceutico.

Country Status (15)

Country Link
US (1) US8455235B2 (es)
EP (1) EP2220220A1 (es)
JP (1) JP2011505160A (es)
KR (1) KR20100092450A (es)
CN (1) CN101889084A (es)
AR (1) AR071261A1 (es)
AU (1) AU2008333313A1 (es)
BR (1) BRPI0819662A2 (es)
CA (1) CA2707658A1 (es)
IL (1) IL205952A0 (es)
MX (1) MX2010005690A (es)
RU (1) RU2010127329A (es)
TW (1) TW200936158A (es)
WO (1) WO2009071550A1 (es)
ZA (1) ZA201003576B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004279924B2 (en) * 2003-10-10 2010-09-30 Novozymes A/S Protease variants
AU2005254611B2 (en) 2004-06-21 2010-09-23 Novozymes A/S Proteases
WO2008077890A1 (en) * 2006-12-22 2008-07-03 Novozymes A/S Method for producing a yeast extract
FR2972639B1 (fr) * 2011-03-18 2013-11-08 Top Pharm Lab Composition pharmaceutique anti-inflammatoire
US20140147895A1 (en) 2011-07-22 2014-05-29 Novozymes A/S Processes for Pretreating Cellulosic Material and Improving Hydrolysis Thereof
US20130273026A1 (en) * 2012-04-12 2013-10-17 Integrative Enzymatics, Inc. Composition and method for modulating inflammatory molecules with amylase
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK564086A (da) 1986-11-25 1988-06-17 Novo Industri As Enzymatisk detergent-additiv
DK173590D0 (da) * 1990-06-06 1990-07-19 Novo Nordisk As Rekombinante terapeutiske lipaser
US5614224A (en) * 1995-04-20 1997-03-25 Womack; Rick W. Nutritional supplement for diabetics
AU6221496A (en) * 1995-05-31 1996-12-18 Simon Lodewijk Scharpe Composition to improve digestibility and utilisation of nutr ients
NL1001620C2 (en) 1995-06-22 1996-12-24 Instituut Voor Agrobiologisch Improvement in activity of plant growth regulators
FR2747045B1 (fr) * 1996-04-05 1998-06-26 Hooreman Michel Nouveau medicament optimisant la viscosite des mucus et ameliorant le fonctionnement de l'intestin
SK284677B6 (sk) 1999-03-17 2005-09-08 Solvay Pharmaceuticals Gmbh Farmaceutický prípravok na liečbu diabetu a spôsob jeho prípravy
DE60115602T2 (de) 2000-02-08 2006-08-10 Dsm Ip Assets B.V. Verwendung von säurestabilen subtilisinproteasen in tierfutter
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
JP4137526B2 (ja) 2002-01-23 2008-08-20 Ｔｏｔｏ株式会社 ケラチナーゼおよびその製造法
AU2003250830A1 (en) 2002-06-12 2003-12-31 Bayer Healthcare Ag Regulation of human subtilase-like serine protease
WO2004111222A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
DK1639104T3 (da) 2003-06-19 2010-07-26 Novozymes As Forbedrede proteaser og fremgangsmåder til fremstilling af disse
WO2004111221A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
US7179630B2 (en) 2003-06-19 2007-02-20 Novozymes A/S Thermostable proteases
WO2004111223A1 (en) 2003-06-19 2004-12-23 Novozymes A/S Proteases
AU2004279924B2 (en) * 2003-10-10 2010-09-30 Novozymes A/S Protease variants
US7985569B2 (en) * 2003-11-19 2011-07-26 Danisco Us Inc. Cellulomonas 69B4 serine protease variants
AU2005247061A1 (en) 2004-05-24 2005-12-08 Novozymes A/S Enzymes for pharmaceutical use
AU2005254611B2 (en) 2004-06-21 2010-09-23 Novozymes A/S Proteases
MX2007015472A (es) 2005-06-24 2008-04-17 Novozymes As Lipasas para uso farmaceutico.
BRPI0611932A2 (pt) 2005-06-24 2011-01-04 Novozymes As amilase, uso da mesma, composição farmacêutica, e, método para o tratamento de uma doença

Also Published As

Publication number Publication date
US20100322915A1 (en) 2010-12-23
IL205952A0 (en) 2010-11-30
TW200936158A (en) 2009-09-01
CA2707658A1 (en) 2009-06-11
AR071261A1 (es) 2010-06-09
ZA201003576B (en) 2011-02-23
US8455235B2 (en) 2013-06-04
CN101889084A (zh) 2010-11-17
AU2008333313A1 (en) 2009-06-11
JP2011505160A (ja) 2011-02-24
KR20100092450A (ko) 2010-08-20
WO2009071550A1 (en) 2009-06-11
BRPI0819662A2 (pt) 2015-06-16
RU2010127329A (ru) 2012-01-10
EP2220220A1 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
DK1755656T3 (da) Enzymer til farmaceutisk anvendelse
MX2007015471A (es) Amilasas para uso farmaceutico.
MX2010005690A (es) Variantes de proteasa para uso farmaceutico.
TW200738256A (en) Lipases for pharmaceutical use
MX2007015474A (es) Proteasas para uso farmaceutico.
MX2009006597A (es) Variantes de lipasa para uso farmaceutico.
GB2511713A (en) Methods of treating behavioral symptoms of neurological and mental disorders
NL300874I2 (nl) Elosulfase alfa
ZA200704247B (en) Stress tolerant cotton plants
WO2010148253A3 (en) Formulations for lysosomal enzymes
MX2009005655A (es) Composiciones y usos de un polipeptido alfa-amilasa del bacilo de la especie 195.
WO2011163648A8 (en) Cns delivery of therapeutic agents
MX354776B (es) Enzimas de reemplazo lisosomal para usarse en el tratamiento de enfermedades de almacenamiento lisosomal.
MY165889A (en) Compositions and methods of using proislet peptides and analogs thereof
WO2008112525A3 (en) Treatment of lysosomal storage diseases
WO2008112459A3 (en) Alkaliphilic bacillus species a-amylase variants, compositions comprising a-amylase variants, and methods of use
MX2012012913A (es) Productos de consumo con variantes de la proteasa.
NZ595364A (en) TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION
TH88730A (th) ไลเปสสำหรับการใช้ทางเภสัชกรรม
TH105721A (th) แวเรียนท์ของไลเปสสำหรับการใช้ทางเภสัชกรรม

Legal Events

Date Code Title Description
FA Abandonment or withdrawal